Felbamate


w217



General information:


Withdrawn ID: w217
Canonical SMILES:
Standard InChI:
Standard InChIKey:
ATC class(es): N03AX10
Molecular Formula: C11H14N2O4
Molweight: 238.24



Withdrawal information:


Withdrawn due to drug safety reasons:Yes
First approved: 1993
First death: 1993
First withdrawn: 1994
Last withdrawn: 1994
Reference: https://www.ncbi.nlm.nih.gov/pubmed/22881467



Side-effects:

Total reported cases (submitted by medical professionals) with Felbamate as primary suspect: 101


Reported final outcomes:
Hospitalization (initial or prolonged): 39
Life-Threatening condition: 10
Death: 8
Intervention required to prevent permanent impairment/damage: 4
Disability: 3
Congenital anomaly: 1


Reported side-effects:

Side-effect Case number
CONVULSION16
PRODUCT SUBSTITUTION ISSUE10
Seizure9
CONDITION AGGRAVATED9
VOMITING8
DECREASED APPETITE8
WEIGHT DECREASED7
PYREXIA7
NAUSEA6
ASTHENIA6
APLASTIC ANAEMIA6
WHITE BLOOD CELL COUNT DECREASED5
PETIT MAL EPILEPSY5
DRUG INEFFECTIVE5
GRAND MAL CONVULSION4
EPILEPSY4
Dysarthria4
DRUG LEVEL DECREASED4
DIARRHOEA4
Balance disorder4
VERTIGO3
Somnolence3
PANCYTOPENIA3
Overdose3
NEUTROPENIA3
DRUG WITHDRAWAL CONVULSIONS3
DRUG INTERACTION3
DIZZINESS3
DEHYDRATION3
AMNESIA3
ALANINE AMINOTRANSFERASE INCREASED3
URINARY TRACT INFECTION2
Unmasking of previously unidentified disease2
TREMOR2
Toxicity to various agents2
STATUS EPILEPTICUS2
PROTEIN TOTAL DECREASED2
PRODUCT QUALITY ISSUE2
PNEUMONIA2
PARTIAL SEIZURES2
No adverse event2
NEPHROLITHIASIS2
MENORRHAGIA2
INFECTION2
INCORRECT DOSE ADMINISTERED2
Headache2
Generalised tonic-clonic seizure2
GASTROOESOPHAGEAL REFLUX DISEASE2
GASTRIC ULCER2
Gamma-glutamyltransferase increased2
FATIGUE2
FALL2
Electrocardiogram repolarisation abnormality2
Electrocardiogram QRS complex prolonged2
Drug hypersensitivity2
Depressed level of consciousness2
Death2
CONSTIPATION2
CHEST PAIN2
BONE MARROW FAILURE2
BLOOD CALCIUM DECREASED2
Atrioventricular block first degree2
Aspartate aminotransferase increased2
Arthralgia2
ANAEMIA2
ALTERED STATE OF CONSCIOUSNESS2
AGRANULOCYTOSIS2
Adverse event2
ABDOMINAL PAIN2
Vitamin D deficiency1
Viral infection1
VERTIGO POSITIONAL1
Ventricular hypokinesia1
Ventricular extrasystoles1
VAGAL NERVE STIMULATOR IMPLANTATION1
TREATMENT NONCOMPLIANCE1
TRANSIENT ISCHAEMIC ATTACK1
THYROID DISORDER1
THROMBOCYTOPENIA1
THROAT TIGHTNESS1
Therapeutic response decreased1
Tachycardia1
Systolic dysfunction1
SYSTEMIC LUPUS ERYTHEMATOSUS1
SUDDEN DEATH1
Stress at work1
Stomatitis1
Stevens-Johnson syndrome1
STARING1
Staphylococcal pharyngitis1
Sputum increased1
SPLENOMEGALY1
Sinus bradycardia1
SIMPLE PARTIAL SEIZURES1
SEPSIS1
SEIZURE CLUSTER1
Sedation1
ROAD TRAFFIC ACCIDENT1
RETICULOCYTE COUNT DECREASED1
RESPIRATORY SYNCYTIAL VIRUS INFECTION1
Renal failure1
REFUSAL OF TREATMENT BY RELATIVE1
REFUSAL OF TREATMENT BY PATIENT1
RED BLOOD CELL COUNT INCREASED1
RED BLOOD CELL COUNT DECREASED1
RED BLOOD CELL ABNORMALITY1
Rectal haemorrhage1
RAYNAUD'S PHENOMENON1
RASH1
PULMONARY EMBOLISM1
PSYCHOMOTOR HYPERACTIVITY1
Product formulation issue1
POST PROCEDURAL NAUSEA1
Poor quality sleep1
POOR QUALITY DRUG ADMINISTERED1
Pneumonia streptococcal1
PLATELET COUNT DECREASED1
Pharyngitis1
PELVIC ABSCESS1
Palpitations1
Pain in extremity1
OVARIAN CYST RUPTURED1
OSTEOPOROSIS1
OSTEOARTHRITIS1
Oropharyngeal pain1
Off label use1
Oesophagitis1
NEUTROPHIL COUNT DECREASED1
NEPHROTIC SYNDROME1
NEPHROSCLEROSIS1
MYOCLONIC EPILEPSY1
Muscle twitching1
Middle insomnia1
METASTASIS1
METABOLIC ACIDOSIS1
Mean cell volume increased1
Maternal exposure during pregnancy1
LUNG INJURY1
Loss of consciousness1
LIVEDO RETICULARIS1
LIQUID PRODUCT PHYSICAL ISSUE1
Lipase increased1
LENNOX-GASTAUT SYNDROME1
KETOACIDOSIS1
Joint injury1
INTENTIONAL DRUG MISUSE1
Insomnia1
INFECTED INSECT BITE1
Infantile spasms1
Increased bronchial secretion1
Incorrect route of drug administration1
Impaired work ability1
IMPAIRED DRIVING ABILITY1
IDIOPATHIC THROMBOCYTOPENIC PURPURA1
HYPOPITUITARISM1
HYPONATRAEMIA1
HYPOMENORRHOEA1
HYPOKALAEMIA1
HYPOAESTHESIA ORAL1
HYPOAESTHESIA1
Hypersensitivity1
Hip fracture1
HEPATITIS CHOLESTATIC1
HEPATITIS ACUTE1
HEPATITIS1
HEPATIC STEATOSIS1
Hepatic failure1
HELICOBACTER INFECTION1
HEAD INJURY1
HAEMORRHAGE1
Glaucoma1
GASTROINTESTINAL DISORDER1
GASTROENTERITIS VIRAL1
GAIT DISTURBANCE1
FUNGAL INFECTION1
Feeding disorder1
FEBRILE NEUTROPENIA1
FACE INJURY1
Extravasation1
EUTHYROID SICK SYNDROME1
EPISTAXIS1
ENTEROBACTER SEPSIS1
ENDOMETRIOSIS1
ENCEPHALITIS VIRAL1
Electrocardiogram ST segment elevation1
EATING DISORDER1
EAR PAIN1
Ear infection1
DYSURIA1
DYSSTASIA1
DYSPNOEA1
Dyskinesia1
DYSFUNCTIONAL UTERINE BLEEDING1
Drug level below therapeutic1
DRUG EXPOSURE DURING PREGNANCY1
DISEASE PROGRESSION1
Diplopia1
Device difficult to use1
DERMATITIS ALLERGIC1
CULTURE URINE POSITIVE1
CRYING1
COOMBS TEST NEGATIVE1
Contusion1
Confusional state1
Colon cancer metastatic1
COGNITIVE DISORDER1
Circulatory collapse1
CHEST DISCOMFORT1
CERVIX CANCER METASTATIC1
CATATONIA1
Cataract1
Carpal tunnel syndrome1
CARDIOTOXICITY1
CARDIAC FAILURE CONGESTIVE1
Cardiac failure1
Cardiac arrest1
CALCULUS BLADDER1
BRONCHIOLITIS1
Brain lobectomy1
BRADYCARDIA1
BONE MARROW DEPRESSION1
BLOOD SODIUM DECREASED1
BLOOD PRESSURE DIASTOLIC DECREASED1
BLOOD PRESSURE DECREASED1
Blood creatinine increased1
Blindness unilateral1
BACTERAEMIA1
Aura1
APPARENT LIFE THREATENING EVENT1
APPARENT DEATH1
ANTINUCLEAR ANTIBODY POSITIVE1
ANTIBODY TEST POSITIVE1
ANENCEPHALY1
Amylase increased1
Aggression1
ADRENAL INSUFFICIENCY1
ADENOCARCINOMA OF THE CERVIX1
Accident1
ABDOMINAL PAIN UPPER1





Filtered ChEMBL targets:

Target UniProtKB ID Activity in nm Target Name Target gene
P14618 10 Pyruvate kinase PKM KPYM_HUMAN
Q16637 39.8 Survival motor neuron protein SMN_HUMAN
Q6W5P4 794.3 Neuropeptide S receptor NPSR1_HUMAN



Toxicity information:

Toxicity class: 4
Toxicity type: neurological
LD50: 1240 mg/kg



External links:

ChEBML: CHEMBL1094
DrugBank: DB00949